Tom Forbes (@Kidney_Tom), one of the authors from this week’s NephJC chat on using stem cells to make organelles to serve as patient specific disease models gives his thoughts on the field and where this study fits.
Background
This week, we aim for an INFINITe allograft lifespan. or flozination in kidney transplant.
Background
This week, we will discuss the POTCAST trial. It is a cardiology trial - but potassium belongs to nephrology.
